Comparison 25. Sensitivity analysis 5, excluding studies with unclear or high risk of bias on incomplete outcome data.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
25.1 Rate of falls ‐ exercise vs control	11	1260	Rate Ratio (IV, Random, 95% CI)	0.77 [0.65, 0.92]
25.2 Number of fallers ‐ exercise vs control	8	736	Risk Ratio (IV, Random, 95% CI)	0.89 [0.79, 1.00]
25.3 Rate of falls ‐ cholinesterase inhibitor vs placebo	1	129	Rate Ratio (IV, Fixed, 95% CI)	0.60 [0.38, 0.96]
25.3.1 Rivastigmine vs placebo	1	129	Rate Ratio (IV, Fixed, 95% CI)	0.60 [0.38, 0.96]
25.4 Number of fallers ‐ cholinesterase inhibitor vs placebo	2	168	Risk Ratio (IV, Fixed, 95% CI)	1.03 [0.92, 1.16]
25.4.1 Rivastigmine vs placebo	1	130	Risk Ratio (IV, Fixed, 95% CI)	1.00 [0.87, 1.15]
25.4.2 Donepezil vs placebo	1	38	Risk Ratio (IV, Fixed, 95% CI)	1.13 [0.90, 1.40]
25.5 Rate of falls ‐ exercise and education vs control	1	124	Rate Ratio (IV, Random, 95% CI)	1.58 [0.74, 3.40]